Myocardial hypertrophy is not a prerequisite for changes in early gene expression in left ventricular volume overload
Authors:
- 27 January 2004
- journal article
- clinical trial
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 18 (1) , 39-44
Abstract
Currently it is not certain whether hypertrophy or the underlying disease is the primary trigger of the alterations in early gene expression in the progression of cardiac disease to end‐stage heart failure. In this study, we tested the notion that in left ventricular overload disorders, the changes in early gene expression in the progression to heart failure is independent of the manifestation of cardiac hypertrophy. We compared the expression of the early genes c‐fos, c‐myc, and c‐jun in six dilated cardiomyopathic hearts (DCM) and 15 patients with left ventricular volume overload (VOL) resulting from mitral/aortic regurgitation and no significant stenosis or hypertrophic manifestations, using eight healthy donor hearts as controls. In VOL, c‐myc was elevated by 88% (P < 0.01) in the left ventricle, 46% in the right ventricle, onefold (P < 0.01) in the left atrium, and 54% (P < 0.05) in the right atrium, while in DCM, it was increased by 71% (P < 0.02), 55%, 48% (P < 0.05) and 91% (P < 0.05), respectively. Similarly, c‐jun was elevated by 41% (P < 0.01) in the left ventricle, 39% (P < 0.05) in the right ventricle, 83% (P < 0.02) in the left atrium and 21% in the right atrium in VOL, while in DCM it was elevated by 13% in the left ventricle, 29% in the left atrium, and 41% in the right atrium, but decreased by 13% in the right ventricle. In contrast, c‐fos was slightly decreased in the left ventricle and atrium of both DCM and VOL, and in left atrium of the VOL group, but remained unchanged in the other myocardial chambers. These results show that, in the human myocardium, the three early genes are regulated differently, possibly in disease‐ and chamber‐specific fashions, and manifestation of left ventricular hypertrophy is not a prerequisite for the elevation in their expression in left ventricular overload disorders.Keywords
This publication has 20 references indexed in Scilit:
- Stage-specific Differential Activation of Mitogen-activated Protein Kinases in Hypertrophied and Failing Rat HeartsJournal of Molecular and Cellular Cardiology, 2001
- Important Role of Angiotensin II–Mediated c-Jun NH2-Terminal Kinase Activation in Cardiac Hypertrophy in Hypertensive RatsHypertension, 2000
- Activation of c-Jun N-Terminal Kinases and p38-Mitogen-activated Protein Kinases in Human Heart Failure Secondary to Ischaemic Heart DiseaseJournal of Molecular and Cellular Cardiology, 1999
- Activation of Mitogen-Activated Protein Kinases in Cardiovascular Hypertrophy and RemodelingThe Japanese Journal of Pharmacology, 1999
- Post-infarction Heart Failure in the Rat is Associated with Distinct Alterations in Cardiac Myocyte Molecular PhenotypeJournal of Molecular and Cellular Cardiology, 1998
- Regional activation of the immediate‐early response gene c ‐fos in infarcted rat heartsInternational Journal of Experimental Pathology, 1998
- Correlation Between Function and Proto-oncogene Expression in Isolated Working Rat Hearts Under Various Overload ConditionsJournal of Molecular and Cellular Cardiology, 1997
- Load effects on gene expression during cardiac hypertrophyJournal of Molecular and Cellular Cardiology, 1995
- Effects of Nisoldipine on Endothelin-1— and Angiotensin II-Induced Immediate/Early Gene Expression and Protein Synthesis in Adult Rat Ventricular CardiomyocytesJournal of Cardiovascular Pharmacology, 1994
- Effect of pressure and volume overload on proto-oncogene expression in the isolated working rat heartCardiovascular Research, 1993